Engage MSI Securing medicines.
Strengthening nations.
The Medicines Security Institute advances the systems, intelligence and international cooperation required to ensure that essential medicines remain safe, available and resilient in an age of geopolitical disruption and technological change.
Medicines are not merely products.
They are strategic infrastructure.
Shortages, concentrated production, fragile logistics, regulatory divergence, antimicrobial resistance and geopolitical competition have moved medicines security to the centre of national resilience.
MSI is being established to define medicines security as a coherent interdisciplinary field—and to turn rigorous evidence into decision advantage for public institutions, industry and society.
Ten domains.
One security system.
MSI studies medicines security across the full chain of national capability—from discovery and regulation to manufacturing, distribution, workforce, capital and future shocks.
Building the field.
Equipping decisions.
Our initial portfolio establishes the concepts, analytical infrastructure and recurring intelligence products needed to make medicines security measurable and actionable.
Strategic Intelligence System
A decision architecture connecting evidence, indicators, scenarios and response options across all ten domains.
Medicines Security Index
A comparative framework for assessing national capability, exposure and resilience.
Medicines Security Papers
A foundational series defining the discipline, its evidence base and implications for public leadership.
Independent intelligence for
high-consequence decisions.
MSI translates interdisciplinary research into carefully scoped policy and executive formats. Engagements are designed around institutional need, evidence quality and public-interest safeguards.
Governments & health systems
National strategy, capability assessment, policy design and executive briefings.
02Pharmaceutical leaders
Supply-chain resilience, geopolitical exposure, manufacturing strategy and organisational readiness.
03Investors & institutions
Decision-relevant intelligence on strategic capacity, dependencies, technology and capital.
04Scholars & researchers
A rigorous interdisciplinary platform for original research, visiting appointments and global exchange.
Credibility must be
constitutional.
MSI is being designed around independence, scholarly rigour, responsible funding and public accountability. Its formal legal status, governing bodies and approved charters will be published as they are established and verified.
David Yusuf
Founder & Executive Director
“Medicines security is the capacity of a society to protect the continuous, equitable and trusted availability of the medicines on which life and national stability depend.”
Help shape a safer,
more resilient medicines future.
We welcome serious dialogue with governments, international institutions, pharmaceutical leaders, research organisations, funders and scholars whose work aligns with MSI’s public-interest mission.
Initiate a confidential conversation Research collaboration · Strategic commissions · Institutional funding · Scholarly appointments